Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 17.38% Profit

May 03, 2023
ELI LILLY AND COMPANY's stock has successfully reached the price target forecast set by QuantWave on December 6, 2022. The forecast indicated a long position with a price of $360.42 at the time of the signal. On May 3, 2023, the stock reached a price of $423.05, yielding a profit of 17.38%.

The achievement of this forecast comes after a period of steady growth for ELI LILLY AND COMPANY, driven by strong financial performance and positive market sentiment towards the company. Factors such as successful product launches, strategic partnerships, and a favorable regulatory environment have contributed to the stock's upward momentum.

This success in hitting the price target highlights the effectiveness of QuantWave's analytics in predicting stock movements and identifying profitable trading opportunities. QuantWave's automated forecasting platform provides users with valuable insights into a wide range of stocks, offering the potential for significant profits.

For investors looking to maximize their returns and gain a deeper understanding of QuantWave's investment strategy, QuantSchool provides a comprehensive professional investment framework. Through QuantSchool, users can learn the key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


GSKJune 12, 2025QuantWave Achieves 14.92% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for GSK PLC, yielding a profit of 14.92%....


DOGE-USDApril 6, 2025QuantWave Achieves 25.26% Profit Target for DOGECOIN USD Forecast  ~1 min.

QuantWave, the automated forecasting platform, has successfully hit the price target forecast for DOGECOIN USD, signaling a short direction on March 4, 2025, when the price was at $0.2....


METAOctober 27, 2022QuantWave Successfully Achieves 24.83% Profit Target Forecast for Meta Platforms, Inc.  ~2 min.

On October 13, 2022, QuantWave, the automated forecasting platform, issued a short signal for META PLATFORMS, INC. (formerly known as Facebook, Inc.) with a price target of $97.41....


BTC-USDDecember 2, 2023BITCOIN USD Hits QuantWave Forecast Target with 28.92% Profit  ~1 min.

BITCOIN USD has successfully reached the price target forecast set by QuantWave on July 2, 2023. The signal indicated a long position at a price of 30620....


VNovember 28, 2024Visa Inc.: Innovating Payments in the Face of Challenges  ~2 min.

Visa Inc. (V), the global leader in digital payments, continues to dominate the industry despite regulatory scrutiny and is bolstering its position through diversification efforts....